Evidence map›Paper›PMID 38188478›Full record

ArticleJournal of hematology2023

Peripheral T-Cell Lymphoma in a Patient Previously Diagnosed With Sarcoidosis.

Sanjay V Menghani, Jessica P Diaz-Hanson, Alex Heimbigner, Chelby Wakefield, Deborah Fuchs, Candace Y Reveles, Catherine Spier, Akshay Amaraneni, Abhijeet Kumar

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of hematology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sanjay V MenghaniUniversity of Arizona College of Medicine - Tucson, Tucson, AZ, USA.ORCID https://orcid.org/0000-0003-2056-1879
Jessica P Diaz-HansonUniversity of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
Alex HeimbignerDepartment of Pathology, University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
Chelby WakefieldBanner Health, Tucson, AZ, USA.
Deborah FuchsDepartment of Pathology, University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
Candace Y RevelesDepartment of Pathology, University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
Catherine SpierDepartment of Pathology, University of Arizona College of Medicine - Tucson, Tucson, AZ, USA.
Akshay AmaraneniBanner Health, Tucson, AZ, USA.
Abhijeet KumarBanner Health, Tucson, AZ, USA.
University of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoidosis is a multisystem disorder characterized by granulomatous inflammation on histopathological evaluation. Diagnosis of sarcoidosis requires thorough elimination of malignancy and alternative causes of noncaseating granulomatous inflammation. Sarcoidosis and several subtypes of lymphoma have similar clinical presentations and can potentially have similar histopathological findings. Patients with a histopathology-confirmed diagnosis of sarcoidosis are at higher risk of developing malignancies. In this report, we present a case of a 64-year-old male diagnosed with sarcoidosis 2 years before presenting to the emergency department with a 4-month history of generalized weakness, cough, and very high fever. After a thorough workup involving cervical lymph node biopsy and bone marrow biopsy, he was diagnosed with peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS). Due to the patient's current lymphoma diagnosis and features noted on pathology, a retrospective review of the prior biopsy specimen was performed, finding similar hematopathological features on both initial lymph node biopsy diagnosing sarcoidosis and current biopsies diagnosing lymphoma. Given these findings, our patient likely had early manifestation of PTCL misdiagnosed as sarcoidosis. In summary, lymphoma should be considered in all patients with suspected sarcoidosis, especially those who do not respond to treatment or who present with persistent hematological abnormalities.

Indexed as

Peripheral T-cell lymphomaSarcoidosisSarcoidosis-lymphoma syndrome

Identifiers

PMID38188478
PMCPMC10769647
OpenAlexW4390340514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.